Urology Times Innovation Celebration Video Series : Episode 32
Video
Urology Times 50 Innovations Series: Sacral neuromodulation
Author(s):
"[Sacral neuromodulation has] changed the treatment of OAB remarkably," says Howard B. Goldman, MD, FACS.
Video Player is loading.
Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Howard Goldman, MD, discusses the development of sacral neuromodulation as a treatment for overactive bladder (OAB). Goldman is a professor of urology and vice chair of the Glickman Urologic Institute at Cleveland Clinic.
Related Videos
Investigators characterize vibegron prescribing patterns for OAB
Laura Bukavina, MD, on trial of radiation with concurrent sacituzumab govitecan in MIBC
Expert outlines advantages of batteryless sacral neuromodulation device
Emmanuel Chartier-Kastler, MD, shares initial data on UroActive System in women with SUI
Smaller size, patient control advantages of neurostimulator for OAB
Laura Bukavina, MD, on microbiome-based biomarkers for treatment response
Batteryless neurostimulator found efficacious at 6-month follow-up
Colin Goudelocke, MD, on 6-month data for batteryless neurostimulator
A physical therapist’s advice for men with post-prostatectomy incontinence
William Furuyama, MD, on community factors’ influence on urinary incontinence
Related Content
